PRRT2 and metabolic disease: Inflammation and metabolic disorders are frequently associated with metabolic dysregulation in the liver and muscles [123,124] because the accumulation of DAG promotes PKC activation while inhibiting insulin receptor activation, resulting in muscle and liver insulin resistance [125,126,127,128].